Pharmacogenetics, Pharmacoepigenetics and Personalized Medicine in Children (R01)

The purpose of this funding opportunity announcement (FOA) is to encourage pharmacogenetic and epigenetic studies and improved phenotypingin childrens pharmacotherapy that will allow individualization of treatment in children.

Audience Tag: 
fundingOpportunityNumber: 
PAR-14-274
Competition Opens: 
07/02/2014
Competition Closes: 
Thursday, September 7, 2017
Agency: 
National Institutes of Health
CFDA: 
93.865
topicTID: 
205
agencyTID: 
6